| http://www.w3.org/ns/prov#value | - IPF is a disease that reduces lung function and eventually leads to disability and death.The drug was approved in October 2008 in Japan, where Shionogi & Co. markets it under the name Pirespa, but there are currently no IPF drugs available in the United States or Europe.
|
